6β-N-Heterocyclic Substituted Naltrexamine Derivative NAP as a Potential Lead to Develop Peripheral Mu Opioid Receptor Selective Antagonists

A 6β-N-heterocyclic substituted naltrexamine derivative, NAP, was proposed as a peripheral mu opioid receptor (MOR) selective antagonist based on the in vitro and in vivo pharmacological and pharmacokinetic studies. To further validate this notion, several functional assays were carried out to fully...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yuan, Yunyun, Stevens, David L., Braithwaite, Amanda, Scoggins, Krista L., Bilsky, Edward J., Akbarali, Hamid I., Dewey, William L., Zhang, Yan
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395321/
https://ncbi.nlm.nih.gov/pubmed/22683223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2012.05.075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados